Gene: CRISPLD2
Official Full Name: cysteine rich secretory protein LCCL domain containing 2provided by HGNC
Gene Summary: Predicted to enable glycosaminoglycan binding activity. Involved in face morphogenesis. Located in transport vesicle. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO03196 | CRISPLD2 Knockout cell line (HeLa) | Human | CRISPLD2 | 1:3~1:6 | Negative | Online Inquiry |
KO03197 | CRISPLD2 Knockout cell line (HCT 116) | Human | CRISPLD2 | 1:2~1:4 | Negative | Online Inquiry |
KO03198 | CRISPLD2 Knockout cell line (A549) | Human | CRISPLD2 | 1:3~1:4 | Negative | Online Inquiry |
CRISPLD2 Gene Knockout Cell Lines are genetically modified cellular models designed to lack the CRISPLD2 gene, which plays a crucial role in various biological processes, including cellular adhesion and tissue remodeling. By utilizing the CRISPR-Cas9 genome-editing technology, these cell lines provide researchers with the ability to study the effects of CRISPLD2 loss, thereby advancing our understanding of its involvement in diseases such as fibrosis and cancer.
The key function of these knockout cell lines lies in their ability to elucidate pathways influenced by CRISPLD2. When this gene is disrupted, cellular behavior and signaling cascades are altered, offering insights into how CRISPLD2 contributes to cellular functions and the mechanisms underlying certain pathological conditions. Such models allow for comprehensive exploration of therapeutic targets and biomarkers in a controlled environment, facilitating drug discovery and basic research.
The scientific significance of CRISPLD2 Gene Knockout Cell Lines is profound, as they enable researchers to dissect the cellular and molecular underpinnings of diseases linked with CRISPLD2 dysregulation. They have applicability across various fields, including regenerative medicine, oncology, and developmental biology, making them invaluable tools in the translational research landscape.
What sets our CRISPLD2 Gene Knockout Cell Lines apart from alternatives is the rigorous validation of the knockout efficiency and the reproducibility of results. Our cell lines come with extensive documentation that outlines their characterization, ensuring researchers can confidently incorporate them into their studies without concerns over background expression.
For researchers and clinicians alike, these products represent an opportunity to investigate novel therapeutic avenues and refine existing treatment modalities. By leveraging our expertise in gene editing technology and cellular biology, we commit to providing high-quality biological products that enhance research productivity and innovation.
With CRISPLD2 Gene Knockout Cell Lines, you gain not just a product but a partner in scientific discovery, backed by our extensive experience in developing cutting-edge biological tools tailored to meet the dynamic needs of the research community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.